ClinicalTrials.Veeva

Menu

Utilizing Free DNA in Embryo Culture for PGT

A

Al Baraka Fertility Hospital

Status

Completed

Conditions

Genetic Diseases, Inborn
Mutation
Chromosome Abnormalities

Treatments

Procedure: NGS reading for Media Free DNA

Study type

Observational

Funder types

Other

Identifiers

NCT02884063
NGS-PGT

Details and patient eligibility

About

In the way for developing and optimizing protocol to be used as non- invasive methodology used as routine testing for PGS.

This protocol is to be adapted to replace the using of life embryo cells for genetic testing and aneuploidy study as well as for any type of genetic testing including single gene disorder or HLA typing or study.

Full description

Compare 100 embryos studied using NGS for chromosomal aneuploidies, and compare the results came from free media DNA with this results.

Enrollment

100 patients

Sex

All

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all abnormal/aneuploidy embryos rejected for embryo transfer.

Exclusion criteria

  • all embryos had unsuccessful diagnosis with blastomere biopsy.

Trial design

100 participants in 2 patient groups

NGS reading for Media Free DNA
Description:
Ability to read the DNA product available in embryo culture media using NGS to have valuable diagnostic image for genetic composition of embryo before implantation.
Treatment:
Procedure: NGS reading for Media Free DNA
NGS reading for blastomer DNA
Description:
DNA extracted from Blastomere used for aneuploidy screening.
Treatment:
Procedure: NGS reading for Media Free DNA

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems